AKR1B10 also regulates fatty acid biosynthesis and lipogenesis [16], detoxifies cytotoxic carbonyls [17], and confers resistance to a number of chemotherapeutic agents used in the treatment of HCC, including anthracyclines and cisplatin (discussed below). The gene discussed is AKR1B10; the disease is hepatocellular carcinoma.